pT3 Substaging is a Prognostic Indicator for Lymph Node Negative Urothelial Carcinoma of the Bladder

Author:

Tilki Derya1,Svatek Robert S.2,Karakiewicz Pierre I.3,Novara Giacomo4,Seitz Michael1,Sonpavde Guru5,Gupta Amit2,Kassouf Wassim6,Fradet Yves7,Ficarra Vincenzo4,Skinner Eila8,Lotan Yair2,Sagalowsky Arthur I.2,Stief Christian G.1,Reich Oliver1,Shariat Shahrokh F.9

Affiliation:

1. Department of Urology, Ludwig-Maximilians-University, Klinikum Grosshadern, Munich, Germany

2. University of Texas Southwestern Medical Center, Dallas, Texas

3. University of Montréal, Montréal, Québec, Canada

4. University of Padua, Padua, Italy

5. Baylor College of Medicine, Houston, Texas

6. McGill University Health Centre, Montréal, Québec, Canada

7. Laval University, Québec City, Québec, Canada

8. University of Southern California, Los Angeles, California

9. Weill Medical College of Cornell University, New York, New York

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Pathology and Staging;A Guide to Management of Urological Cancers;2023

2. Utility of pT3 substaging in lymph node-negative urothelial carcinoma of the bladder: do pathologic parameters add to prognostic sub-stratification?;World Journal of Urology;2021-04-21

3. AJCC Staging of Bladder Cancers;Urinary Bladder Pathology;2021

4. Neoplasms of the Urinary Bladder;Urologic Surgical Pathology;2020

5. ♂♀ Transitional Cell Tumors of the Bladder;Gynecologic and Urologic Pathology;2019-02-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3